Intra-Cellular Therapies, Inc. (ITCI)

Intra-Cellular Therapies Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Operating Activities

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-74.68	-139.67	-256.26	-284.13	-227.01
Depreciation & Amortization	0.51	0.53	0.66	0.53	0.53
Loss (Gain) From Sale of Investments	-9.03	-8.4	0.45	-4.08	-0.65
Stock-Based Compensation	64.12	52.92	43.1	34.48	24.33
Change in Accounts Receivable	-52.48	-38.83	-55.03	-9.39	-10.77
Change in Inventory	-14.91	-26.35	-15.97	-0.89	-7.06
Change in Accounts Payable	14.62	1.06	1.7	3.19	-1.92
Change in Other Net Operating Assets	-1.33	34.54	11.17	0.74	-7.8
Operating Cash Flow	-73.18	-124.2	-270.19	-259.54	-230.07
Operating Cash Flow Growth	-	-	-	-	-

Investing Activities

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Capital Expenditures	-0.32	-0.27	-0.78	-0.33	-0.27
Investment in Securities	-334.83	105.81	-127.6	280.67	-480.03
Investing Cash Flow	-335.15	105.54	-128.37	280.34	-480.3

Financing Activities

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Issuance of Common Stock	567.51	17.81	455.16	11.52	664.18
Financing Cash Flow	567.51	17.81	455.16	11.52	664.18

Net Cash Flow

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Cash Flow	159.18	-0.85	56.6	32.32	-46.19

Free Cash Flow

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Free Cash Flow	-73.5	-124.47	-270.96	-259.87	-230.34
Free Cash Flow Growth	-	-	-	-	-
Free Cash Flow Margin	-10.79%	-26.80%	-108.25%	-310.10%	-1009.69%
Free Cash Flow Per Share	-0.71	-1.30	-2.88	-3.20	-3.27
Levered Free Cash Flow	-63.55	-28.97	-180.85	-150.04	-148.8
Unlevered Free Cash Flow	-63.55	-28.97	-180.85	-150.04	-148.8

Additional Metrics

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash Income Tax Paid	1.82	0.16	0.01	0.01	0

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error